An interventional study of Buddhist walking meditation in Hemolysis and Restless Legs Syndrome, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-02-04.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
the restless leg syndrome is a common complaint in person who undergo hemodialysis. Buddhist walking meditation efficacy was not investigated in those population
the total participants will be 40. all patients will be on hemodialyis. they complain restless leg syndrome. the participants will be divided to group I which received Buddhist walking meditation. this program of meditation will be 30 minutes thrice weekly. before and after buddhist meditation walking, there will be 5 minutes stretching exercises working as warm up or cooling down respectively. the other group will serve as control one .. the number of patient in every group will be 20. the total duration of Buddhist walking meditation will be 12 weeks.
120 studies on the registry are indexed under Hemolysis; 22 are open to participants now.
This study's planned enrollment of 40 is below the median of 49 across 78 interventional studies indexed under Hemolysis.
Browse Hemolysis studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
the participants will be on hemodialyis. they complain restless leg syndrome. the participants will receive Buddhist walking meditation. this program of meditation will be 30 minutes thrice weekly. before and after Buddhist walking meditation .. the number of patients in the group will be 20. the total duration of Buddhist walking meditation will be 12 weeks.
Behavioral: Buddhist walking meditation
the participants will be on hemodialyis. they complain restless leg syndrome. the number of patients in the group will be 20. this group will be control group that will not receive training .
the participants will be on hemodialyis. they complain restless leg syndrome. the participants will receive Buddhist walking meditation. this program of meditation will be 30 minutes thrice weekly. before and after Buddhist walking meditation .. The number of patients in the group will be 20. the total duration of Buddhist walking meditation will be 12 weeks.
international RLS Study Group Rating
it will assess the severity of the problem (restless leg syndrome)
Time frame: it will be measured after 12 weeks
Pittsburg sleep quality index
it will assess sleep quality
Time frame: it will be measured after 12 weeks
fatigue severity scale
it will assess fatigue level
Time frame: it will be measured after 12 weeks
sit to stand test
it will assess number of sit to stand in 30 seconds
Time frame: it will be measured after 12 weeks
physical component of short form 12
a questionnaire will assess physical abilities of patients
Time frame: it will be measured after 12 weeks
mental component of short form 12
a questionnaire will assess mental status of patients
Time frame: it will be measured after 12 weeks
beck depression inventory
a questionnaire will assess depression status of patients
Time frame: It will be measured after 12 weeks
Trait Anxiety Inventory
it will assess anxiety in patients
Time frame: it will be measured after 12 weeks
diatolic blood pressure
it will be assessed manually
Time frame: it will be measured after 12 weeks
systolic blood pressure
it will be assessed manually
Time frame: it will be measured after 12 weeks
cortisol
it will be measured in serum
Time frame: It will be measured after 12 weeks
C reactive protein
it will be measured in serum
Time frame: It will be measured after 12 weeks
nitric oxide
it will be measured in serum
Time frame: It will be measured after 12 weeks
Started Nov 2024 (actual). Primary completion is estimated for Mar 2025, 4 months after the start.
Of 28 interventional studies with no phase under Hemolysis, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 35. This study's planned 4 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.